Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, ...

I maintain my Buy rating on Teladoc Health due to positive acquisitions and a robust balance sheet, despite recent weak Q1 ...

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...

Teladoc Health stock price surged by over 14% on Monday, its best single-day gain since April 9. What next for the TDOC share ...

Teladoc Health (TDOC) stock rallies as Citron Research issues a bullish report on the company. Read more here.

Teladoc (TDOC) shares rallied 14.4% in the last trading session to close at $7.89. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session ...

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential ...

Teladoc’s first quarter results surpassed Wall Street’s revenue and EPS expectations, providing a measure of reassurance to investors. Management identified several factors behind the recent ...

But TDOC again canceled its procurement when Centurion filed a protest. The letter from the state's Central Procurement Office sent March 18 explained the cancellation by merely stating, ...